Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A.

about

Outcome of Clinical Trials with New Extended Half-Life FVIII/IX Concentrates.Novel therapies and current clinical progress in hemophilia A.Extended Half-Life Factor VIII and Factor IX Preparations.Practical aspects of extended half-life products for the treatment of haemophilia

P2860

Q39204747-975C63FE-74BB-4542-97B6-CC2F44F3B33C Q49745450-AE724C1F-5820-4BA3-A78F-2E4E7C3D6A37 Q55025596-A0FA948E-6B6C-4079-842C-2CC933594C4D Q58761664-7FD3610C-92F2-492A-9B21-EF8E98C32775

P2860

Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A.

Item

http://www.wikidata.org/entity/Q45862229

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Extended half-life pegylated, ...... ren with severe haemophilia A.

@en

Extended half-life pegylated, ...... ren with severe haemophilia A.

@nl

type

Item

label

Extended half-life pegylated, ...... ren with severe haemophilia A.

@en

Extended half-life pegylated, ...... ren with severe haemophilia A.

@nl

prefLabel

Extended half-life pegylated, ...... ren with severe haemophilia A.

@en

Extended half-life pegylated, ...... ren with severe haemophilia A.

@nl

P1476

Extended half-life pegylated, ...... ren with severe haemophilia A.

@en

P2093

B E Abbuehl

http://www.w3.org/2001/XMLSchema#string

D Osman

http://www.w3.org/2001/XMLSchema#string

M Sharkhawy

http://www.w3.org/2001/XMLSchema#string

M T Alvarez-Román

http://www.w3.org/2001/XMLSchema#string

O Stasyshyn

http://www.w3.org/2001/XMLSchema#string

R Liesner

http://www.w3.org/2001/XMLSchema#string

W Engl

http://www.w3.org/2001/XMLSchema#string

P2860

Haemophilia A: pharmacoeconomic review of prophylaxis treatment versus on-demand

Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspective.

Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A

A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management

Pathogenesis of haemophilic arthropathy.

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.

Modern haemophilia care.

Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale.

P304

238-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HAE.13119

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eric S Mullins

P577

2016-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27891721

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

hemophilia A

Coagulation factor VIII

Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A.

about

P2860

P2860

Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921